Serena Williams and the GLP-1 Weight-Loss Campaign

When Serena Williams appeared in an ad campaign endorsing GLP-1 weight-loss injections, the backlash was immediate. As a globally recognised athlete and role model, her promotion of a prescription-only treatment was seen as irresponsible. Critics argued that the campaign blurred the line between healthcare and beauty marketing, normalised the use of medical drugs for aesthetic purposes, and ignored the risks of advertising medication directly to consumers.

For many, the issue wasn’t Serena’s personal decision to use the treatment — it was the fact that it was packaged and sold back to the public as aspirational, with no acknowledgment of the medical safeguards such drugs require.